Dong Wang, MD, PhD

Dong Wang, MD, PhD

Chief Physician · Associate Professor

Beijing

Chief Physician, Associate Professor, and master's supervisor in Hepatobiliary Surgery at Peking University People's Hospital. He completed advanced training at UCLA, MSKCC, and Cleveland Clinic in the United States.

Peking University People's Hospital

Hepatobiliary Surgery

Clinical focus Portal Hypertension · Primary Liver Cancer · Liver Transplantation

Biliary Tract TumorsPancreatic TumorsMinimally Invasive Hepatobiliary Surgery

About the doctor

Dr. Dong Wang is Chief Physician and Associate Professor of Hepatobiliary Surgery at Peking University People's Hospital and supervises master's students. He also serves as Deputy Director of the hospital's Infection Management Office. He earned a doctorate in medicine from Peking University Health Science Center and completed advanced training in the United States at the University of California, Los Angeles (UCLA), Memorial Sloan Kettering Cancer Center (MSKCC), and Cleveland Clinic. His clinical focus includes portal hypertension, primary liver cancer, liver transplantation, surgery for biliary tract and pancreatic tumors, and minimally invasive surgical techniques. He also conducts research on comprehensive cancer treatment. He has served as chief editor and lead translator for books including Hepatobiliary Surgery Operative Techniques, Perioperative Fluid Therapy in General Surgery, and Atlas of Liver Transplantation. He has published more than 20 articles in journals in China and abroad. According to his CV, his academic roles include Deputy Lead of the Portal Hypertension Expert Working Group of the Chinese College of Surgeons and Vice Chair of the Hepatobiliary Oncology Committee of the Beijing Chronic Disease Prevention and Health Education Research Association. If you are seeking a surgical assessment for liver cancer, portal hypertension, or a biliary tract or pancreatic tumor, the sections below outline questions you can discuss at your consultation. Whether you need surgery and which treatment is appropriate depend on a review of your full medical records and an in-person assessment.

Clinical areas

A liver tumor (primary or metastatic) has been found: is surgical treatment an option?

If imaging has found a liver lesion or liver cancer has been diagnosed and you want to understand whether surgical removal is an option, this is an area you can discuss at a consultation. The doctor usually reviews contrast-enhanced CT or MRI, liver function, overall condition, and treatment history to assess the extent of disease and operability before discussing next steps.

Portal hypertension: surgical assessment and treatment options

Patients with cirrhosis-related portal hypertension, hypersplenism, or previous gastrointestinal bleeding can discuss the direction of surgical assessment at a consultation, including splenic function, portal venous imaging, and bleeding risk. The specific approach (such as shunting, devascularization, or other management) is determined by the treating team based on the individual condition.

Biliary or pancreatic tumors: understanding surgical treatment options

Diagnosis and treatment planning for cholangiocarcinoma, gallbladder cancer, or pancreatic cancer require multidisciplinary assessment. At a consultation you can discuss whether imaging and pathology records are complete, whether the lesion is resectable, and how surgery and comprehensive therapy can be coordinated; specific arrangements are determined after evaluation by the treating team.

End-stage liver disease: learning about liver transplant evaluation

If you have end-stage liver disease, you can ask your doctor about the usual steps in liver transplant evaluation and which records to prepare. A qualified transplant team decides whether and when you can begin evaluation or join the waiting list, in accordance with applicable national regulations and your individual circumstances.

Professional highlights

  • 01Doctorate in medicine from Peking University and master's supervisor. Currently Chief Physician and Associate Professor of Hepatobiliary Surgery at Peking University People's Hospital
  • 02Advanced training in the United States at UCLA, Memorial Sloan Kettering Cancer Center (MSKCC), and Cleveland Clinic
  • 03Chief editor and lead translator of several books, including Hepatobiliary Surgery Operative Techniques. Published more than 20 articles in journals in China and abroad
  • 04Deputy Lead of the Portal Hypertension Expert Working Group of the Chinese College of Surgeons, among other academic roles (per doctor's CV)

Professional experience

  1. Doctorate in medicine, Peking University Health Science Center

  2. Present

    Chief Physician, Associate Professor, and Master's Supervisor, Hepatobiliary Surgery, Peking University People's Hospital

  3. Present

    Deputy Director, Infection Management Office, Peking University People's Hospital

  4. Advanced training in the United States at the University of California, Los Angeles (UCLA), Memorial Sloan Kettering Cancer Center (MSKCC), and Cleveland Clinic

  5. Deputy Lead, Portal Hypertension Expert Working Group, Chinese College of Surgeons (per doctor's CV)

  6. Vice Chair, Hepatobiliary Oncology Committee, Beijing Chronic Disease Prevention and Health Education Research Association (per doctor's CV)

  7. Standing Member, Biliary Stone Surgery Expert Committee, Chinese Chapter of the International Hepato-Pancreato-Biliary Association (per doctor's CV)

  8. Chief editor and lead translator of Hepatobiliary Surgery Operative Techniques, Perioperative Fluid Therapy in General Surgery, Atlas of Liver Transplantation, and other books

  9. Published more than 20 articles in journals in China and abroad. Editorial board member of the Chinese Journal of Clinical Medicine (Electronic Edition) and member of the Small Intestine and Pancreas Transplantation Group of the Chinese Society of Organ Transplantation

Hospital and department

Peking University People's Hospital

Founded in 1918, Peking University People's Hospital is a Grade III, Class A general hospital affiliated with Peking University and serves as the university's Second Clinical Medical College. Its campuses include Xizhimen, Baitasi, and Tongzhou.

Hepatobiliary Surgery

The Department of Hepatobiliary Surgery provides surgical treatment for portal hypertension, primary liver cancer, liver transplantation, and biliary and pancreatic tumors, as well as minimally invasive techniques and comprehensive tumor therapy (per the hospital's official department description).

Before you seek care

Records to prepare

Consider preparing contrast-enhanced abdominal CT or MRI images and reports, blood test results including liver function tests, prior treatment and surgical records, pathology reports if you have had a needle biopsy or surgery, and a current medication list. For an assessment of portal hypertension, also prepare endoscopy or imaging records. The hospital will confirm which records are required.

Appointment arrangements

The hospital's website lists regular hepatobiliary surgery specialist clinics on Monday morning, Tuesday afternoon, and Friday morning. Campus, schedule, and availability can change; refer to the hospital's official appointment channels for the latest arrangement.

  • Seek immediate care at the nearest emergency department for symptoms such as acute major upper gastrointestinal bleeding, severe abdominal pain with fever and jaundice, or altered consciousness.
  • This page cannot determine whether surgery is needed or whether a liver transplant is appropriate. It cannot replace an in-person consultation, a review of your imaging, or an assessment of perioperative risk by your treating team.
Dong Wang, MD, PhDGet care support
Contact Us